Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| 17-alpha-Estradiol | Liothyronine (T3) | |
|---|---|---|
| Category | Hormones | Hormones |
| Standard Dose | — | — |
| Timing | — | — |
| Cycle Duration | — | — |
| Evidence Level | Preclinical | Strong |
Non-feminizing estrogen that extends lifespan in male mice via metabolic improvements. Reduces hepatic mTOR signaling, improves glucose homeostasis, and reduces inflammation without estrogenic effects on reproductive tissues.
Synthetic triiodothyronine that directly raises active thyroid hormone signaling.
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →